{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T06:28:55Z","timestamp":1763706535581,"version":"3.41.2"},"reference-count":59,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDR"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>About 50.8 million people were diagnosed with diabetes in 2011; the count has increased\nby 10 million in the last five years. Type-1 diabetes could occur at any age, but predominantly\nin children and young adults. The risk of developing type II diabetes mellitus in the offspring\nof parents with DM II is 40% if one parent has DM II and approaches 70% if both parents\nhave DM II. The process of developing diabetes from normal glucose tolerance is continuous, with\ninsulin resistance being the first stage. As prediabetes progresses slowly to DM II, it may take approximately\n15-20 years for an individual to become diabetic. This progression can be prevented or\ndelayed by taking some precautions and making some lifestyle amendments, e.g., reducing weight\nby 5-7% of total body weight if obese, etc. Retinoblastoma protein is one of the pocket proteins\nthat act as crucial gatekeepers during the G1\/S transition in the cell cycle. A loss or defect in single-\ncell cycle activators (especially CDK4 and CDK6) leads to cell failure. In diabetic or stress\nconditions, p53 becomes a transcription factor, resulting in the transactivation of CKIs, which leads\nto cell cycle arrest, cell senescence, or cell apoptosis. Vitamin D affects insulin sensitivity by increasing\ninsulin receptors or the sensitivity of insulin receptors to insulin. It also affects peroxisome\nproliferator-activated receptors (PPAR) and extracellular calcium. These influence both insulin\nresistance and secretion mechanisms, undertaking the pathogenesis of type II diabetes. The\nstudy confines a marked decrement in the levels of random and fasting blood glucose levels upon\nregular vitamin D intake, along with a significant elevation of retinoblastoma protein levels in the\ncirculatory system. The most critical risk factor for the occurrence of the condition came out to be\nfamily history, showing that patients with first-degree relatives with diabetes are more susceptible.\nFactors such as physical inactivity or comorbid conditions further aggravate the risk of developing\nthe disease. The increase in pRB levels caused by vitamin D therapy in prediabetic patients directly\ninfluences blood glucose levels. pRB is supposed to play a role in maintaining blood sugar levels.\nThe results of this study could be used for further studies to evaluate the role of vitamin D and pRB\nin regeneration therapy for beta cells in prediabetics.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573399819666230331083715","type":"journal-article","created":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T04:03:36Z","timestamp":1680494616000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effect of Vitamin D on Retinoblastoma Protein in Prediabetic Individuals"],"prefix":"10.2174","volume":"20","author":[{"given":"Dakshita","family":"Hardatt","sequence":"first","affiliation":[{"name":"MM College of Pharmacy, MM (Deemed to be University), Mullana, Ambala, HR, 133207, India"},{"name":"Chandigarh Group of\nColleges (CGC)-Landran, Sector-112, Landran, Kharar Banur Hwy, Sahibzada Ajit Singh Nagar, Punjab-140307, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manju","family":"Devi","sequence":"additional","affiliation":[{"name":"MM College of Pharmacy, MM (Deemed to be University), Mullana, Ambala, HR, 133207, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonal","family":"Vyas","sequence":"additional","affiliation":[{"name":"Index Institute of Pharmacy, Malwanchal University, Indore, Morodhat, MP -452016, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gurvinder","family":"Singh","sequence":"additional","affiliation":[{"name":"MM College of Pharmacy, MM (Deemed to be University), Mullana, Ambala, HR, 133207, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyoti","family":"Jain","sequence":"additional","affiliation":[{"name":"MM College of Pharmacy, MM (Deemed to be University), Mullana, Ambala, HR, 133207, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumeet","family":"Gupta","sequence":"additional","affiliation":[{"name":"MM College of Pharmacy, MM (Deemed to be University), Mullana, Ambala, HR, 133207, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9097-341X","authenticated-orcid":true,"given":"Meenakshi","family":"Dhanawat","sequence":"additional","affiliation":[{"name":"Amity Institute of Pharmacy,\nAmity University Haryana, Amity Education Valley, Panchgaon, Manesar, Gurugram, Haryana -122413, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","author":"Nakrani M.N.","year":"2022","unstructured":"Nakrani M.N.; Wineland R.H.; Anjum F.;  StatPearls  2022","journal-title":"StatPearls"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.2337\/dc09-S062","volume":"32","year":"2009","unstructured":"Diagnosis and classification of diabetes mellitus. Diabetes Care American Diabetes Association 2009,32(S1),S62-S67","journal-title":"Diabetes Care"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1515\/rjdnmd-2016-0012","volume":"23","author":"Sandu M-M.","year":"2016","unstructured":"Sandu M-M.; Protasiewicz D.C.; Fir\u0103nescu AG, L\u0103c\u0103tu\u015fu EC, B\u00eecu ML, \u0163a M. Data regarding the prevalence and incidence of diabetes mellitus and prediabetes. Rom J Diabetes Nutr Metab Dis  2016,23(1),95-103","journal-title":"Rom J Diabetes Nutr Metab Dis"},{"year":"2015","key":"ref=4","unstructured":"Sujatha . Prevalence of Diabetes in India 2015"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/S2213-8587(17)30174-2","volume":"5","author":"Anjana R.M.","year":"2017","unstructured":"Anjana R.M.; Deepa M.; Pradeepa R.; Prevalence of diabetes and prediabetes in 15 states of India: Results from the ICMR\u2013INDIAB population-based cross-sectional study. Lancet Diabetes Endocrinol  2017,5(8),585-596","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.4066\/AMJ.2014.1979","volume":"7","author":"Kaveeshwar S.","year":"2014","unstructured":"Kaveeshwar S.; Cornwall J.; The current state of diabetes mellitus in India. Australas Med J  2014,7(1),45-48","journal-title":"Australas Med J"},{"key":"ref=7","first-page":"1","volume":"22","author":"Mohan V.","year":"2009","unstructured":"Mohan V.; Pradeepa G.R.; Epidemiology of diabetes in different regions of India. Health Administrator  2009,22(1),1-18","journal-title":"Health Administrator"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"17016","DOI":"10.1038\/nrdp.2017.16","volume":"3","author":"Katsarou A.","year":"2017","unstructured":"Katsarou A.; Gudbj\u00f6rnsdottir S.; Rawshani A.; Type 1 diabetes mellitus. Nat Rev Dis Primers  2017,3(1),17016","journal-title":"Nat Rev Dis Primers"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"903","DOI":"10.3390\/molecules22060903","volume":"22","author":"Dom\u00ednguez Avila J.","year":"2017","unstructured":"Dom\u00ednguez Avila J.; Rodrigo Garc\u00eda J.; Gonz\u00e1lez Aguilar G.; de la Rosa L.; The antidiabetic mechanisms of polyphenols related to increased glucagon-like peptide-1 (GLP1) and insulin signaling. Molecules  2017,22(6),903","journal-title":"Molecules"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/ejcn.2011.118","volume":"65","author":"Mitri J.","year":"2011","unstructured":"Mitri J.; Muraru M.D.; Pittas A.G.; Vitamin D and type 2 diabetes: A systematic review. Eur J Clin Nutr  2011,65(9),1005-1015","journal-title":"Eur J Clin Nutr"},{"key":"ref=11","first-page":"447","volume":"12","author":"Prabhu S.","year":"2013","unstructured":"Prabhu S.; Genetic and biochemical risk factors for type 2 diabetes mellitus. Indian J Biotechnol  2013,12(4),447-450","journal-title":"Indian J Biotechnol"},{"key":"ref=12","unstructured":"One part of managing type 2 diabetes is managing A1C. Available from:  https:\/\/www.niddk.nih.gov\/health-information\/diabetes\/over view\/risk-factors-type-2-diabetes"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1161\/01.HYP.37.4.1053","volume":"37","author":"Sowers J.R.","year":"2001","unstructured":"Sowers J.R.; Epstein M.; Frohlich E.D.; Diabetes, hypertension, and cardiovascular disease: An update. Hypertension  2001,37(4),1053-1059","journal-title":"Hypertension"},{"key":"ref=14","doi-asserted-by":"publisher","DOI":"10.5005\/jp\/books\/11091","author":"Mohan H.","year":"2010","unstructured":"Mohan H.;  Textbook of pathology  2010","journal-title":"Textbook of pathology"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/nature05616","volume":"445","author":"Sladek R.","year":"2007","unstructured":"Sladek R.; Rocheleau G.; Rung J.; A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature  2007,445(7130),881-885","journal-title":"Nature"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"179","DOI":"10.2337\/dc15-1585","volume":"39","author":"Schwartz S.S.","year":"2016","unstructured":"Schwartz S.S.; Epstein S.; Corkey B.E.; Grant S.F.A.; Gavin J.R.; Aguilar R.B.; The time is right for a new classification system for diabetes: Rationale and implications of the \u03b2-cell\u2013centric classification schema. Diabetes Care  2016,39(2),179-186","journal-title":"Diabetes Care"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"114","DOI":"10.4239\/wjd.v4.i4.114","volume":"4","author":"Ali O.","year":"2013","unstructured":"Ali O.; Genetics of type 2 diabetes. World J Diabetes  2013,4(4),114-123","journal-title":"World J Diabetes"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s00125-012-2715-x","volume":"56","author":"Scott R.A.","year":"2013","unstructured":"Scott R.A.; Langenberg C.; Sharp S.J.; The link between family history and risk of type 2 diabetes is not explained by anthropometric, lifestyle or genetic risk factors: The EPIC-InterAct study. Diabetologia  2013,56(1),60-69","journal-title":"Diabetologia"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1177\/1010539514555861","volume":"27","author":"Muktabhant B.","year":"2015","unstructured":"Muktabhant B.; Sanchaisuriya P.; Trakulwong M.; Mingchai R.; Schelp F.P.; A first-degree relative with diabetes mellitus is an important risk factor for rural Thai villagers to develop type 2 diabetes mellitus. Asia Pac J Public Health  2015,27(4),385-393","journal-title":"Asia Pac J Public Health"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"177","DOI":"10.4103\/jncd.jncd_82_22","volume":"7","author":"Gupta M.","year":"2022","unstructured":"Gupta M.; Saini R.; Jaswal S.; Lehl S.; Jesrani G.; Gupta S.; Prevalence of risk factors for diabetes in adult offspring of type 2 diabetes mellitus patients. Int J Noncommun Dis  2022,7(4),177","journal-title":"Int J Noncommun Dis"},{"key":"ref=21","first-page":"1","volume":"3","author":"Bhalerao S.D.","year":"2014","unstructured":"Bhalerao S.D.; Somannavar M.; Risk factors for type-2 diabetes mellitus in rural population of north karnatka: A community-based cross sectional study. Int J Pharma Bio Sci  2014,3(1),1-14","journal-title":"Int J Pharma Bio Sci"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1046\/j.1365-2362.32.s3.3.x","volume":"32","author":"Boden G.","year":"2002","unstructured":"Boden G.; Shulman G.I.; Free fatty acids in obesity and type 2 diabetes: Defining their role in the development of insulin resistance and \u03b2-cell dysfunction. Eur J Clin Invest  2002,32(S3),14-23","journal-title":"Eur J Clin Invest"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1172\/JCI118742","volume":"97","author":"Roden M.","year":"1996","unstructured":"Roden M.; Price T.B.; Perseghin G.; Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest  1996,97(12),2859-2865","journal-title":"J Clin Invest"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12915-015-0140-6","volume":"13","author":"Cantley J","year":"2015","unstructured":"Cantley J; Ashcroft FM. Q; andA: Insulin secretion and type 2 diabetes: Why do \u03b2-cells fail? BMC Biol  2015,13(1),33","journal-title":"BMC Biol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1007\/s12020-012-9830-9","volume":"43","author":"Bergman M.","year":"2013","unstructured":"Bergman M.; Pathophysiology of prediabetes and treatment implications for the prevention of type 2 diabetes mellitus. Endocrine  2013,43(3),504-513","journal-title":"Endocrine"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.2337\/dc16-S010","volume":"39","year":"2016","unstructured":"Approaches to glycemic treatment. Diabetes Care American Diabetes Association 2016,39(S1),S52-S59","journal-title":"Diabetes Care"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.2522\/ptj.20080020","volume":"88","author":"Deshpande A.D.","year":"2008","unstructured":"Deshpande A.D.; Harris-Hayes M.; Schootman M.; Epidemiology of diabetes and diabetes-related complications. Phys Ther  2008,88(11),1254-1264","journal-title":"Phys Ther"},{"key":"ref=28","author":"IDF Diabetes Atlas","year":"2016","unstructured":"IDF Diabetes Atlas;  7th ed International Diabetes Federation  2016","journal-title":"7th ed International Diabetes Federation"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.37506\/ijphrd.v11i3.2396","volume":"3","author":"Junedi S.","year":"2020","unstructured":"Junedi S.; Nuhaedar J.; Characteristics of outpatient pre diabetes dr. dody sarjoto. Indian J Public Health Res Dev  2020,3(1),2058-2061","journal-title":"Indian J Public Health Res Dev"},{"key":"ref=30","unstructured":"Insulin Resistance and Prediabetes"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1016\/S0140-6736(12)60283-9","volume":"379","author":"Hamiel P.O.","year":"2013","unstructured":"Hamiel P.O.; Zeitler P.; Prediabetes: A high-risk state for developing diabetes. Lancet  2013,379(9833),2279-2290","journal-title":"Lancet"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1016\/S0140-6736(12)60283-9","volume":"379","author":"Tab\u00e1k A.G.","year":"2012","unstructured":"Tab\u00e1k A.G.; Herder C.; Rathmann W.; Brunner E.J.; Kivim\u00e4ki M.; Prediabetes: A high-risk state for diabetes development. Lancet  2012,379(9833),2279-2290","journal-title":"Lancet"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/j.1399-5448.2007.00336.x","volume":"8","author":"Weiss R.","year":"2007","unstructured":"Weiss R.; Impaired glucose tolerance and risk factors for progression to type 2 diabetes in youth. Pediatr Diabetes  2007,8(S9),70-75","journal-title":"Pediatr Diabetes"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"861","DOI":"10.7326\/M15-2345","volume":"163","author":"Siu A.L.","year":"2015","unstructured":"Siu A.L.; Screening for abnormal blood glucose and type 2 diabetes mellitus: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med  2015,163(11),861-868","journal-title":"Ann Intern Med"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/EP15672.GLSUPPL","volume":"21","author":"Handelsman Y.","year":"2015","unstructured":"Handelsman Y.; Bloomgarden Z.T.; Grunberger G.; American association of clinical endocrinologists and american college of endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan-2015. Endocr Pract  2015,21(S1),1-87","journal-title":"Endocr Pract"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.2337\/dc15-S005","volume":"38","year":"2015","unstructured":"(2) Classification and diagnosis of diabetes. Diabetes Care American Diabetes Association 2015,38(S1),S8-S16","journal-title":"Diabetes Care"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1503\/cmaj.120732","volume":"184","author":"Pottie K.","year":"2012","unstructured":"Pottie K.; Jaramillo A.; Lewin G.; Recommendations on screening for type 2 diabetes in adults. CMAJ  2012,184(15),1687-1696","journal-title":"CMAJ"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.diabet.2010.09.006","volume":"37","author":"Makrilakis K.","year":"2011","unstructured":"Makrilakis K.; Liatis S.; Grammatikou S.; Validation of the Finnish diabetes risk score (FINDRISC) questionnaire for screening for undiagnosed type 2 diabetes, dysglycaemia and the metabolic syndrome in Greece. Diabetes Metab  2011,37(2),144-151","journal-title":"Diabetes Metab"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"19","DOI":"10.24095\/hpcdp.32.1.04","volume":"32","author":"Robinson C.A.","year":"2011","unstructured":"Robinson C.A.; Agarwal G.; Nerenberg K.; Validating the CANRISK prognostic model for assessing diabetes risk in Canada\u2019s multi-ethnic population. Chronic Dis Inj Can  2011,32(1),19-31","journal-title":"Chronic Dis Inj Can"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.2337\/dc14-S081","volume":"37","year":"2014","unstructured":"Diagnosis and classification of diabetes mellitus. Diabetes Care American Diabetes Association 2014,37(S1),S81-S90","journal-title":"Diabetes Care"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"882","DOI":"10.2337\/db08-0631","volume":"58","year":"2009","unstructured":"Bigatel TA. Survey of human pancreatic  \u03b2-cell G1\/ S proteome reveals a potential therapeutic role for cdk-6 and cyclin D1 in enhancing human  \u03b2-cell replication and function In vivo. Diabetes Fiaschi-TN 2009,58(4),882-893","journal-title":"Diabetes"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2337\/db06-0517","volume":"56","author":"Vasavada R.C.","year":"2007","unstructured":"Vasavada R.C.; Cozar-Castellano I.; Sipula D.; Stewart A.F.; Tissue-specific deletion of the retinoblastoma protein in the pancreatic beta-cell has limited effects on beta-cell replication, mass, and function. Diabetes  2007,56(1),57-64","journal-title":"Diabetes"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1038\/sj.onc.1208619","volume":"24","author":"Cobrinik D.","year":"2005","unstructured":"Cobrinik D.; Pocket proteins and cell cycle control. Oncogene  2005,24(17),2796-2809","journal-title":"Oncogene"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1126\/science.1411535","volume":"258","author":"Nevins J.R.","year":"1992","unstructured":"Nevins J.R.; E2F: A link between the Rb tumor suppressor protein and viral oncoproteins. Science  1992,258(5081),424-429","journal-title":"Science"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"6914","DOI":"10.1073\/pnas.90.15.6914","volume":"90","author":"Flemington E.K.","year":"1993","unstructured":"Flemington E.K.; Speck S.H.; Kaelin W.G.; E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product. Proc Natl Acad Sci USA  1993,90(15),6914-6918","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=46","first-page":"7813","volume":"13","author":"Lees J.A.","year":"1993","unstructured":"Lees J.A.; Saito M.; Vidal M.; The retinoblastoma protein binds to a family of E2F transcription factors. Mol Cell Biol  1993,13(12),7813-7825","journal-title":"Mol Cell Biol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1101\/gad.1046102","volume":"16","author":"Lee C.","year":"2002","unstructured":"Lee C.; Chang J.H.; Lee H.S.; Cho Y.; Structural basis for the recognition of the E2F transactivation domain by the retinoblastoma tumor suppressor. Genes Dev  2002,16(24),3199-3212","journal-title":"Genes Dev"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/0092-8674(89)90507-2","volume":"58","author":"DeCaprio J.A.","year":"1989","unstructured":"DeCaprio J.A.; Ludlow J.W.; Lynch D.; The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell  1989,58(6),1085-1095","journal-title":"Cell"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/0092-8674(90)90590-b","volume":"60","author":"Ludlow J.W.","year":"1990","unstructured":"Ludlow J.W.; Shon J.; Pipas J.M.; The retinoblastoma susceptibility gene product undergoes cell cycle-dependent dephosphorylation and binding to and release from SV40 large T. Cell  1990,60(3),387-396","journal-title":"Cell"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/0092-8674(92)90107-N","volume":"70","author":"Helin K.","year":"1992","unstructured":"Helin K.; Lees J.A.; Vidal M.; Dyson N.; Harlow E.; Fattaey A.; A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell  1992,70(2),337-350","journal-title":"Cell"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"102","DOI":"10.4161\/cc.1.2.108","volume":"1","author":"Blagosklonny M.V.","year":"2002","unstructured":"Blagosklonny M.V.; Pardee A.B.; The restriction point of the cell cycle. Cell Cycle  2002,1(2),102-109","journal-title":"Cell Cycle"},{"key":"ref=52","first-page":"501","volume":"20","author":"Pestell R.G.","year":"1999","unstructured":"Pestell R.G.; Albanese C.; Reutens A.T.; Segall J.E.; Lee R.J.; Arnold A.; The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation. Endocr Rev  1999,20(4),501-534","journal-title":"Endocr Rev"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1210\/er.2006-0004","volume":"27","author":"Cozar-Castellano I.","year":"2006","unstructured":"Cozar-Castellano I.; Fiaschi-Taesch N.; Bigatel T.A.; Molecular control of cell cycle progression in the pancreatic  \u03b2-cell. Endocr Rev  2006,27(4),356-370","journal-title":"Endocr Rev"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"R61","DOI":"10.1530\/JOE-16-0324","volume":"231","author":"Kung C.P.","year":"2016","unstructured":"Kung C.P.; Murphy M.E.; The role of the p53 tumor suppressor in metabolism and diabetes. J Endocrinol  2016,231(2),R61-R75","journal-title":"J Endocrinol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.jsbmb.2014.07.011","volume":"144","author":"Hummel D","year":"2014","unstructured":"Hummel D; Aggarwal A; Borka K; Bajna E; K\u00e1llay E; Horv\u00e1th HC; The vitamin D system is deregulated in pancreatic diseases. J Steroid Biochem Mol Biol  2014,144(Pt B),402-9","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"S491","DOI":"10.1093\/ajcn\/88.2.491S","volume":"88","author":"Norman A.W.","year":"2008","unstructured":"Norman A.W.; From vitamin D to hormone D: Fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr  2008,88(2),S491-S499","journal-title":"Am J Clin Nutr"},{"key":"ref=57","first-page":"47","volume":"18","author":"Hoseini S.A.","year":"2013","unstructured":"Hoseini S.A.; Aminorroaya A.; Iraj B.; Amini M.; The effects of oral vitamin D on insulin resistance in pre-diabetic patients. J Res Med Sci  2013,18(1),47-51","journal-title":"J Res Med Sci"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"9296","DOI":"10.3390\/ijms21239296","volume":"21","author":"Bhoora S.","year":"2020","unstructured":"Bhoora S.; Punchoo R.; Policing cancer: Vitamin D arrests the cell cycle. Int J Mol Sci  2020,21(23),9296","journal-title":"Int J Mol Sci"},{"author":"Vitamin D.","key":"ref=59","unstructured":"Vitamin D.;"}],"container-title":["Current Diabetes Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573399819666230331083715","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/215281\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573399819666230331083715","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T17:03:42Z","timestamp":1708621422000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/215281\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573399819666230331083715","relation":{},"ISSN":["1573-3998"],"issn-type":[{"type":"print","value":"1573-3998"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-10-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-12","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e310323215281"}}